These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 14201316)

  • 21. COAGULATION STUDIES IN EXTRACORPOREAL CIRCULATION.
    DYBKJAER E; BERG E; KISSMEYER-NIELSEN F
    Acta Chir Scand; 1964 Oct; 128():350-61. PubMed ID: 14211290
    [No Abstract]   [Full Text] [Related]  

  • 22. ROLE OF THROMBIN IN PROTHROMBIN ACTIVATION.
    SEEGERS WH; SCHROEER H; HEENE D
    Thromb Diath Haemorrh; 1964 Dec; 12():484-8. PubMed ID: 14254705
    [No Abstract]   [Full Text] [Related]  

  • 23. MODIFICATIONS OF THE COAGULATION MECHANISM DURING PREGNANCY.
    PHILLIPS LL
    Mod Trends Hum Reprod Physiol; 1963; 15():190-204. PubMed ID: 14115154
    [No Abstract]   [Full Text] [Related]  

  • 24. [BLOOD CLOTTING FACTOR IN HEMOLYSATES].
    OGIWARA Y
    Nihon Ketsueki Gakkai Zasshi; 1963 Dec; 26():779-87. PubMed ID: 14154695
    [No Abstract]   [Full Text] [Related]  

  • 25. COAGULATION STUDIES IN HEMOPHILIOID DISEASES: THEIR IMPORTANCE IN TREATMENT PLANNING.
    MEYER I
    J Oral Surg Anesth Hosp Dent Serv; 1964 Jul; 22():324-31. PubMed ID: 14155476
    [No Abstract]   [Full Text] [Related]  

  • 26. [General mechanisms of coagulation and their physiological inhibition. I. General mechanisms of blood coagulation].
    Guillin MC; Bezeaud A
    Pathol Biol (Paris); 1985 Oct; 33(8):847-57. PubMed ID: 3903625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Theory of blood coagulation: applications in disseminated intravascular coagulation.
    Seegers WH; McCoy L; Marciniak E; Murano G
    Thromb Diath Haemorrh Suppl; 1969; 36():239-68. PubMed ID: 4914021
    [No Abstract]   [Full Text] [Related]  

  • 28. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy.
    Gieseler F; Lühr I; Kunze T; Mundhenke C; Maass N; Erhart T; Denker M; Beckmann D; Tiemann M; Schulte C; Dohrmann P; Cavaillé F; Godeau F; Gespach C
    Thromb Haemost; 2007 Jun; 97(6):1023-30. PubMed ID: 17549306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet coagulation-protein interactions.
    Walsh PN
    Semin Thromb Hemost; 2004 Aug; 30(4):461-71. PubMed ID: 15354267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complexes of protein-free lipid thromboplastin and prothrombin conversion factors; identifiable intermediates in the coagulation of blood.
    MANN FD; HURN MM
    Am J Physiol; 1955 Aug; 182(2):319-24. PubMed ID: 13258809
    [No Abstract]   [Full Text] [Related]  

  • 31. [EVALUATION OF METHODS FOR THE DETERMINATION OF THE PROTHROMBIN COMPLEX ACTIVITY].
    MARES J; PODLIPNY J
    Z Arztl Fortbild (Jena); 1964 Jun; 58():709-13. PubMed ID: 14240434
    [No Abstract]   [Full Text] [Related]  

  • 32. Blood clotting mechanisms: three basic reactions.
    Seegers WH
    Annu Rev Physiol; 1969; 31():269-94. PubMed ID: 4179722
    [No Abstract]   [Full Text] [Related]  

  • 33. [METHOD OFSTUDY OF BLOOD COAGULATION BASED ON THE CHANGES IN ELECTRIC RESISTANCE OF THE FIBRINNETWORK].
    BAYOBAYO JM; ZULUAGAJARAMILLO E
    Arch Inst Farmacol Exp (Madr); 1963; 15():75-93. PubMed ID: 14049389
    [No Abstract]   [Full Text] [Related]  

  • 34. [THE PHYSIOPATHOLOGY OF FIBRINOLYSIS AND ITS CLINICAL AND THERAPEUTIC APPLICATIONS].
    SAMAMA M
    Transfusion (Paris); 1964; 7():99-125. PubMed ID: 14168287
    [No Abstract]   [Full Text] [Related]  

  • 35. Standardization of the Quick prothrombin test; with reference to the statistical significance of variations in the prothrombin concentration with use of a stable thromboplastin of high potency.
    AGGELER PM; HOWARD J
    Blood; 1946 May; 1():220-33. PubMed ID: 21026403
    [No Abstract]   [Full Text] [Related]  

  • 36. [EXPERIMENTAL STUDIES ON THE EFFECT OF CIGARETTE SMOKING ON THE COAGULATION TIME OF NORMAL BLOOD AND CALCIUM-TREATED BLOOD AND ON THE PROTHROMBIN AND THROMBIN TIME OF HUMAN SERUM].
    LISIEWICZ J
    Pol Tyg Lek; 1963 Sep; 18():1471-3. PubMed ID: 14082331
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies on prothrombin; purification, inactivation with thrombin, and activation with thromboplastin and calcium.
    WARE AG; SEEGERS WH
    J Biol Chem; 1948 Jun; 174(2):565-75. PubMed ID: 18865622
    [No Abstract]   [Full Text] [Related]  

  • 38. Pathogenesis of disseminated intravascular coagulation.
    Larrieu MJ
    Southeast Asian J Trop Med Public Health; 1979 Sep; 10(3):321-4. PubMed ID: 515795
    [No Abstract]   [Full Text] [Related]  

  • 39. The procoagulant effect of thrombin on fibrin(ogen)-bound platelets.
    Sanders MW; Nieuwenhuys CM; Feijge MA; Rook M; Béguin S; Heemskerk JW
    Haemostasis; 1998; 28(6):289-300. PubMed ID: 10461011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A factor in serum which accelerates the conversion of prothrombin to thrombin; its relationship to the coagulation defect of thrombocytopenic blood.
    ALEXANDER B; DE VRIES A
    Blood; 1949 Jun; 4(6):747-51. PubMed ID: 18129760
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.